The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about many questions as hospitals and blood centers prepare to order the testing. We've put together a FAQ document to clarify what we know today. We will update the document as we get more information on existing questions and as new questions get asked, and will update the blog with the revised FAQ document.
Thanks for your support as we work to rapidly get this testing available to you. You can find the FAQ document here: CTS COVID-19 Questions and Answers
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...
Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
This is the first update to the original CTS communication distributed on July 6th. As previously co...